August 08, 2016 BY Valentina Kirilova

LSE announces UnaVista's earlier MIFIR transaction launch

London Stock Exchange Group (LSE) has announced that UnaVista, its MiFID Approved Reporting Mechanism (ARM), has made user acceptance testing available for MiFIR transaction reporting 17 months ahead of schedule. UnaVista is the LSE group’s global hosted platform for all matching, validation and reconciliation needs. It offers a range of business solutions through one interface…

Read more
August 08, 2016 BY Valentina Kirilova

ASIC's enforcement report highlights key enforcement outcomes for January-June 2016

ASIC has released its enforcement report for the period January 1, 2016 to June 30, 2016. The report highlights ASIC's long-term challenges and areas of focus going forward, as well as outcomes supporting those areas, including: balancing a free-market system with investor and financial consumer protection; digital disruption; structural change; financial innovation-driven complexity; and globalisation.…

Read more
August 08, 2016 BY Valentina Kirilova

Hong Kong SFC adds Rhino Asia to its alert list

Hong Kong’s financial regulator the Securities and Futures Commission (SFC) has updated its Alert List, which features the names of businesses that are unlicensed in Hong Kong and are believed to be, or to have been, targeting Hong Kong investors or claim to have an association with Hong Kong. Added to the SFC Alert List…

Read more
August 08, 2016 BY Valentina Kirilova

TriOptima completes first triReduce compression cycle for cleared Mexican Peso swaps at CME Group

Post trade infrastructure provider TriOptima, part of ICAP plc (LON:IAP), has announced that 11 CME Group IRS clearing members eliminated 12.5 trillion MXN ($664 billion USD) notional outstanding in the first triReduce multilateral compression cycle for cleared Mexican Peso (MXN) interest rate swaps (IRS). Over 35% of the cleared MXN notional principal outstanding in CME…

Read more
August 08, 2016 BY Valentina Kirilova

Australian drug development company Noxopharm to list on ASX

Australian drug development company Noxopharm (ASX:NOX) has been successfully listed on Australia Securities Exchange (ASX) and will begin trading on Tuesday, August 9, 2016 at 11 am (AEST), after the Initial Public Offer raised the target figure of 6 million Australian dollars. The offer of 30 million shares at a price of $0.20 a share,…

Read more
August 08, 2016 BY Valentina Kirilova

FCA warns on clone firm CF Investment Funds

Today the UK Financial Conduct Authority put out details of the cloned firm CF Investment Funds. Fraudsters are using the details of firms, authorised by the FCA, to try to convince people that they work for a genuine, authorised firm. The clone firm are using or giving out the following details as part of their…

Read more
August 08, 2016 BY LeapRate Staff

KVB Kunlun revenues dive 21% in Q2, profits fall 61%

Hong Kong Forex retail forex broker KVB Kunlun Financial Group Ltd (HKG:8077) had its slowest quarter in a year and a half, reporting that Q2 revenues were down 21% from Q1, leading to a 61% QoQ drop in profits. KVB brought in revenues of HK$ 83.8 million (USD $10.9 million) in Q2, its lowest quarterly…

Read more